Retatrutide 5mg+cagrilintide 5mg

Compound Overview

Research Use Only. Not for Human Consumption.

Retatrutide 5mg+cagrilintide 5mg is supplied by Nexus as a Nexus-only multi-peptide research blend for controlled in-vitro laboratory workflows. The catalog configuration is a 10mg total blend, with 5mg assigned to the retatrutide component and 5mg assigned to the cagrilintide component.

The supplied research record classifies this item as a multi-peptide blend in the GLP-1 & Metabolic category. It is described as a dual-incretin/amylin-pathway research blend, with retatrutide identified as the triple agonist peptide component and cagrilintide identified as the amylin analog component. Because the item is a blend rather than a single isolated compound, the provided data does not assign a single CAS number, molecular formula, molecular weight, or sequence to the finished vial.

The available source data for this blend is intentionally limited. This page does not add unsupported component chemistry, published citations, sequence data, purity values, batch identifiers, dosage guidance, or biological outcome claims. Component-specific chemistry should be reviewed through the individual retatrutide and cagrilintide records where those records are available.

Research Background & Published Literature

The research source identifies RC10 as a Nexus-only blend combining a retatrutide component and a cagrilintide component. The product-level record does not include blend-specific peer-reviewed citations, clinical claims, component sequences, or a product-specific literature bibliography. For that reason, this description stays at the catalog and analytical-verification level rather than extending into unsupported mechanistic detail.

At the component level, the record provides only the following research classifications: retatrutide is listed as a triple agonist peptide component, and cagrilintide is listed as an amylin analog component. The blend is categorized for GLP-1 and metabolic research workflows, but the supplied data does not provide a validated experimental protocol, target concentration, assay design, or intended model system. Researchers should treat this page as a product identity and handling summary, not as a literature review or experimental-methods guide.

No product-specific citations were supplied in the research data for this blend. To avoid filling source gaps with guesses, no citations are listed here.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Jastreboff et al. (2023) — N Engl J Med
• Enebo et al. (2021) — Lancet

Storage, Handling & Stability Guidelines

Store lyophilized material at -20°C, desiccated and protected from light. After reconstitution, separate the material into aliquots appropriate for the laboratory workflow and avoid repeated freeze-thaw cycles. These handling instructions are especially important for a blend record where the finished product contains two peptide components and the supplied data does not provide separate blend-specific stability studies.

• Keep the lyophilized vial sealed until it is ready for controlled laboratory preparation.
• Protect stored material from moisture and direct light exposure.
• After reconstitution, use aliquoting to reduce repeated freeze-thaw stress.
• Label prepared aliquots with compound name, reconstitution date, operator initials, and any laboratory-specific tracking identifiers.
• Follow institutional procedures for handling research peptides and lyophilized laboratory reagents.

Lab Verification

Nexus maintains verification records for research compounds through the Lab Verified archive. For a multi-peptide blend such as Retatrutide 5mg+cagrilintide 5mg, appropriate analytical review should verify both component identities and the mass allocation described by the product record.

The provided research data does not include exact Certificate of Analysis values, batch numbers, purity percentages, HPLC retention times, or MS mass results for this item. Accordingly, this page references HPLC/MS verification only in general terms. High-Performance Liquid Chromatography can support chromatographic review, and Mass Spectrometry can support identity confirmation, but no blend-specific numerical results are stated here because none were provided in the source data.